Refreshing results…
Genetic Heterogeneity and Tissue-specific Patterns of Tumors with MultiplePIK3CAMutations
Download from aacrjournals.orgPhase and context shape the function of composite oncogenic mutations
Download from www.nature.comHER2-Mediated Internalization of Cytotoxic Agents inERBB2Amplified or Mutant Lung Cancers
Download from aacrjournals.orgDouble PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
UploadTRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
UploadNeratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
Uploadp95HER2–T cell bispecific antibody for breast cancer treatment
UploadMissing publications? Search for publications with a matching author name.